Admedus is a structural heart company delivering clinically superior solutions that help healthcare professionals create life-changing outcomes for patients. Its focus is on investing in and developing next generation technologies with world class partners and acquiring strategic assets to grow product and service offerings. The company has assets from research & development through clinical development and sales, marketing and distribution.

Our Technology

Our proprietary ADAPT® engineering process produces implantable tissue bioscaffolds for a range of cardiovascular and vascular applications.


Annual General Meeting
Our CEO Wayne Paterson presenting on the vision for Admedus at this years Annual General Meeting in Brisbane, Australia. To...
Read more.

Admedus shares fly 40pc on first trading day in six months.
The EACTS lunchtime symposium highlighted to over 110 Cardiac Surgeons the benefits of the Next Generation ADAPT Bi…
Successful case out of Baylor College of Medicine - The Children's Hospital of San Antonio. Dr. Daniel Nento and Dr…